About Smoking Cessation Products
Smoking cessation products such as NRTs and e-cigarettes have proved useful in reducing the numbers of smokers worldwide. They can also be used to reduce smoking. A substantial number of smokers are now either quitting or trying to reduce smoking. This is because of increased awareness about the adverse effects of smoking; it is associated with a number of health hazards that can eventually lead to death. This is encouraging people to adopt smoking cessation products. Public awareness programs help create awareness about the hazards of smoking, and also the availability of products that help quit smoking.
Technavio’s analysts forecast the global smoking cessation products market to grow at a CAGR of 18.16% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global smoking cessation products market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, off-label, and over-the-counter (OTC) products used for smoking cessation.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Thoracic Surgery Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• GlaxoSmithKline
• Imperial Tobacco
• NJOY
• Pfizer
• Reynolds American
Other prominent vendors
• 22nd Century Group
• Alkalon
• Altria Group
• Aradigm
• Arena Pharmaceuticals
• Ballantyne Brands
• British American Tobacco (BAT)
• CB Distributors
• Cytos Biotechnology
• Electronics Cigarettes International Group (Victory Electronic Cigarettes)
• Evotec
• Gamucci
• Japan Tobacco
• Johnson & Johnson
• LOGIC Technology
• NAL Pharmaceuticals
• Nicotek
• Novartis
• Revolymer
• RR Chemicals
• Selecta Biosciences
• Target
• The Harvard Drug Group
• Vapor
• VMR Products
• Walgreens
• Wal-Mart
• White Cloud
Market driver
• High awareness of risks associated with tobacco use
• For a full, detailed list, view our report
Market challenge
• Relapse after treatment
• For a full, detailed list, view our report
Market trend
• Ban on tobacco advertisements
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: World cigarette statistics: Per capita consumption per year
PART 06: Epidemiology
• US
PART 07: Health implications of smoking
• Risk of tobacco smoke on non-smokers
PART 08: Regulations on tobacco use
• Impact of smoking bans on businesses
• Economic benefits to individuals
PART 09: Pipeline analysis
• NAL2762
• X-22
• APD356
• GSK598809
• SEL-068
• ARD-1600
PART 10: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 11: Market segmentation by type
• Global smoking cessation drugs market
• Global NRTs market
• Global e-cigarette market
PART 12: Market segmentation by availability
• Prescription products
• OTC products
PART 13: Geographical segmentation
• Global smoking cessation products market by geography 2015-2020
• Smoking cessation products market in Americas
• Smoking cessation products market in EMEA
• Smoking cessation products market in APAC
PART 14: Market drivers
• Increase in number of smokers
• Increase in teenage smoking
• Significant number of public awareness programs
• High awareness of risks associated with tobacco use
PART 15: Impact of drivers
PART 16: Market challenges
• Side effects associated with drugs and therapies
• Relapse after treatment
• Weak R&D on drugs
PART 17: Impact of drivers and challenges
PART 18: Market trends
• Increase in use of e-cigarettes
• Increased innovation in smoking cessation products
• Ban on tobacco advertisements
• Increased pictorial warnings on cigarette packages
PART 19: Vendor landscape
• Competitive scenario
• GlaxoSmithKline
• Imperial Tobacco
• NJOY
• Pfizer
• Reynolds American
• Other prominent vendors
PART 20: Appendix
• List of abbreviations
PART 21: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Common health effects caused by smoking
Exhibit 03: Smoking cessation products: Pipeline portfolio
Exhibit 04: Discontinued projects
Exhibit 05: Global smoking cessation products market 2015-2020 ($ billions)
Exhibit 06: Five forces analysis
Exhibit 07: Global smoking cessation products market by type
Exhibit 08: Global smoking cessation products market by type 2015
Exhibit 09: Global smoking cessation drugs market 2015-2020 ($ billions)
Exhibit 10: Global NRTs market 2015-2020 ($ billions)
Exhibit 11: Global NRTs market by product 2015
Exhibit 12: Global nicotine patch market 2015-2020 ($ billions)
Exhibit 13: Nicotine patch market by geographical region 2015
Exhibit 14: Global nicotine gum market 2015-2020 ($ billions)
Exhibit 15: Nicotine gum market by geographical region 2015
Exhibit 16: Global e-cigarette market 2015-2020 ($ billions)
Exhibit 17: Global e-cigarette market: Product life cycle analysis 2015
Exhibit 18: E-cigarette market by geographical region 2015
Exhibit 19: Global smoking cessation products market by availability
Exhibit 20: Global smoking cessation products market by geography 2015
Exhibit 21: Global smoking cessation products market by geography 2020
Exhibit 22: Global smoking cessation products market revenue by geography 2015-2020 ($ billions)
Exhibit 23: Smoking cessation products market in Americas 2015-2020 ($ billions)
Exhibit 24: Smoking cessation products market in EMEA 2015-2020 ($ billions)
Exhibit 25: Smoking cessation products market in APAC 2015-2020 ($ billions)
Exhibit 26: Impact of drivers
Exhibit 27: Impact of drivers and challenges
Exhibit 28: Implementation of picture warnings in various countries
Exhibit 29: GlaxoSmithKline: Business segmentation by revenue 2014
Exhibit 30: GlaxoSmithKline: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 31: GlaxoSmithKline: Geographical segmentation by revenue 2014
Exhibit 32: GlaxoSmithKline: Key takeaways
Exhibit 33: Imperial Tobacco: Business segmentation by revenue 2014
Exhibit 34: Imperial Tobacco: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 35: Imperial Tobacco: Key takeaways
Exhibit 36: NJOY: Product categories
Exhibit 37: NJOY: Key takeaways
Exhibit 38: Pfizer: Business segmentation by revenue 2014
Exhibit 39: Pfizer: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 40: Pfizer: Geographical segmentation by revenue 2014
Exhibit 41: Pfizer: YoY growth and revenue of Chantix or Champix ($ millions)
Exhibit 42: Pfizer: Key takeaways
Exhibit 43: Reynolds American: Business segmentation by revenue 2014
Exhibit 44: Reynolds American: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 45: Reynolds American: Key takeaways
